|
|
 |
October 21, 2008 |
Now Available:
Watch podcasts of the Expert Rheumatology Exchange video series
CME Meetings:
Musculoskeletal Report provides cutting-edge scientific updates through biweekly and special edition newsletters, in-depth interviews, and on-location coverage of medical meetings.
With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.
Online CME Opportunity:
Procedures: Cutting Better Than Splinting for Carpal Tunnel Pain, Numbness, Weakness
A Cochrane review concludes that surgery is better than splinting for relieving the symptoms of carpal tunnel syndrome, and that a head-to-head comparison of surgery versus steroid injections is needed...
Skin: Gleevec/CYC Combo Emerging as Novel Approach for Scleroderma Lung Disease
Adding the oncology drug imatinib (Gleevec) to cyclophosphamide offers a 2-pronged strategy that might be effective in scleroderma-associated pulmonary complications...
Consumer News: Bone Health Organizations Around the Globe Mark World Osteoporosis Day
October 20th is World Osteoporosis Day, which launches a campaign to mobilize public opinion to generate change in osteoporosis healthcare policies...
BioPharm Business: Centocor Reports Efficacy of Remicade vs Azathioprine in Treatment of Crohn's Disease
Azathioprine is not approved in the US for the treatment of CD but is approved in some countries outside the US and is widely used by gastroenterologists and other physicians in the US to treat CD patients...
BioPharm Business: UCB's Cimzia (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
A large study investigating endoscopic improvement in Crohn's disease (CD) demonstrated that Cimzia (certolizumab pegol), the only PEGylated anti-TNFα biologic, significantly improved endoscopic lesions and induced endoscopic response...